# Carenostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/carenostics

- Industry: Healthcare IT
- Headquarters: Berwyn, US
- Website: www.carenostics.com
- Total disclosed funding: $4.7M
- Latest round: Seed (Sep 1, 2023)
- Investors on record: 3

## About

Founded in 2021 by Kanishka Rao (COO) and Bharat Rao (CEO), and based in Pennsylvania, US, Carenostics Inc. operates as a developer of a healthcare platform that helps in the early detection of chronic diseases in patients to enable timely intervention and prevention by medical professionals. In September 2023, Carenostics Inc. raised USD 5 million in seed funding led by new investor M13, with participation from other new investors Gaingels Syndicate and GreatPoint Ventures.

The firm offers a software platform powered by machine learning and artificial intelligence to help in the early detection of chronic diseases like asthma, kidney disease, diabetes, or cancer. The platform integrates AI-based solutions with existing health data identifies undiagnosed and undertreated chronic disease patients and prompts clinicians within their current workflows to intervene earlier. The firm's flagship product, CKDx, is a clinical decision support tool that is used for the eradication of undiagnosed chronic kidney diseases.

The company intends to use the September 2023 funding to support its expansion.

## Funding rounds

- Seed, Sep 1, 2023, $4.7M — GreatPoint Ventures, Gaingels, M13

## Investors

- GreatPoint Ventures (https://capitalatlas.ai/funds/greatpoint-ventures) — Seed
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Seed
- M13 (https://capitalatlas.ai/funds/m13) — Seed